logo
Sign in

VIVS Stock Price, Chart, Stats & News

VivoSim Labs, Inc.
Save
2.95M
Market cap
0.66x
Current P/E
Forward P/E

VIVS chart

1M
3M
1Y
5Y
Loading chart...

Fundamentals

Gross margin
100.00%
Operating margin
-8066.20%
Pretax margin
-862.68%
Net margin
-864.08%
Effective tax rate
-0.16%
ROA
-17.63%
ROE
-15.56%
D/E
0.13x
Interest coverage ratio
-881.08x

VIVS valuation

P/E
0.66x
P/S
29.75x
P/B
0.53x
P/CF
-0.22x
P/FCF
-0.40x
P/OCF
-0.22x
PEG
-0.06x
EV multiple
-8.11x

About

VivoSim Labs, Inc. is a biotechnology company dedicated to developing sophisticated 3D tissue models designed to replicate key aspects of human diseases. At the heart of their operations is a proprietary 3D human tissue platform, which incorporates their advanced NovoGen Bioprinters. These automated devices are engineered to construct intricate 3D living tissues using mammalian cells, alongside complementary technologies vital for preparing specialized bio-inks and for the precise bioprinting of multi-cellular tissues with complex architectural designs.

Similar securities

Based on sector and market capitalization

Report issue